These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1814816)

  • 1. [Effect of HFMC injection of various concentrations on patency of vas deferens and resumption of fertility in rats].
    Xiang D; Luo Z
    Hua Xi Yi Ke Da Xue Xue Bao; 1991 Sep; 22(4):379-83. PubMed ID: 1814816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A study on the effective way and dosage of intravas deferens injection of HFMC for male contraception].
    Yue L; He Y; Zhang J; Zeng H; Luo Z; Xu R
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Dec; 26(4):408-10. PubMed ID: 8732062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A study on autoimmune response against spermatozoa following intravas deferens injection of high molecular hydrogel HFMC in rabbits].
    He Y; Luo Z; Xu C
    Hua Xi Yi Ke Da Xue Xue Bao; 1991 Sep; 22(4):384-6. PubMed ID: 1814817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel mode of contraception using polymeric hydrogels. I.
    Singh H; Vasudevan P; Misro M; Ray AR; Guha SK
    J Biomed Mater Res; 1982 Jan; 16(1):3-9. PubMed ID: 7056760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Injectable non-occlusive chemical contraception in the male-I.
    Misro M; Guha SK; Singh H; Mahajan S; Ray AR; Vasudevan P
    Contraception; 1979 Nov; 20(5):467-73. PubMed ID: 43211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Male contraceptive -- the biological compatibility evaluation of hydrogel HFMC].
    Li GG; Huang PH; Sun T; Ma MF; Luo ZQ
    Shengzhi Yu Biyun; 1992 Apr; 12(2):56-9. PubMed ID: 12285893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative suitability of DMSO and NaHCO3 for reversal of RISUG® induced long-term contraception.
    Ansari AS; Hussain M; Khan SR; Lohiya NK
    Andrology; 2016 Mar; 4(2):306-13. PubMed ID: 26748683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histological changes in the vas deferens of rats after injection of a new male antifertility agent "SMA" and its reversibility.
    Sethi N; Srivastava RK; Singh RK
    Contraception; 1990 Mar; 41(3):333-9. PubMed ID: 2323221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contraception in male monkeys by intra-vas deferens injection of a pH lowering polymer.
    Guha SK; Ansari S; Anand S; Farooq A; Misro MM; Sharma DN
    Contraception; 1985 Jul; 32(1):109-18. PubMed ID: 4053602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of a high molecular copolymer HFMC in vaginal irrigation for contraception in mice].
    Zeng HA; Luo ZQ
    Hua Xi Yi Ke Da Xue Xue Bao; 1989 Dec; 20(4):389-91. PubMed ID: 2630417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Histopathological study of human vas deferens sterilized by intraluminal adhesive agent injection].
    Ye XZ
    Shengzhi Yu Biyun; 1986 Aug; 6(3):32-4. PubMed ID: 12268663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II clinical trial of a vas deferens injectable contraceptive for the male.
    Guha SK; Singh G; Ansari S; Kumar S; Srivastava A; Koul V; Das HC; Malhotra RL; Das SK
    Contraception; 1997 Oct; 56(4):245-50. PubMed ID: 9408706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contraception with RISUG
    Ansari AS; Badar A; Balasubramanian K; Lohiya NK
    Asian J Androl; 2017; 19(4):389-395. PubMed ID: 27586026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes of free amino acids in seminal plasma with vasectomy and reanastomosis of the vas deferens (author's transl)].
    Nakayama K; Murakami N; Miura K; Shirai M; Ando K
    Nihon Funin Gakkai Zasshi; 1981 Apr; 26(2):12-6. PubMed ID: 12158576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reversible injection occlusion of vas deferens: animal experimentation and clinical application].
    Zhao SC
    Shengzhi Yu Biyun; 1986 Feb; 6(1):12-7. PubMed ID: 12267912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RISUG (reversible inhibition of sperm under guidance)--an antimicrobial as male vas deferens implant for HIV free semen.
    Guha SK
    Med Hypotheses; 2005; 65(1):61-4. PubMed ID: 15893119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphological observations of vas deferens occlusion by the percutaneous injection of medical polyurethane.
    Chen Z; Gu Y; Liang X; Shen L; Zou W
    Contraception; 1996 May; 53(5):275-9. PubMed ID: 8724616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a single ethanol injection into the vas deferens on the testicular function of rats.
    Dixit VP; Angrawal M; Lohiya NK
    Endokrinologie; 1976 Mar; 67(1):8-13. PubMed ID: 1244202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of castration on the smooth muscle cells of the internal sex organs of the rat: influence of the smooth muscle on the sympathetic neurons innervating the vas deferens, seminal vesicle and coagulating gland.
    Wakade AR; Garcia AG; Kirpekar SM
    J Pharmacol Exp Ther; 1975 May; 193(2):424-34. PubMed ID: 1142099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of genotoxicity in leukocytes and testis following intra-vasal contraception with RISUG and its reversal by DMSO and NaHCO₃ in Wistar albino rats.
    Ansari AS; Alam I; Hussain M; Khan SR; Lohiya NK
    Reprod Toxicol; 2013 Apr; 36():53-9. PubMed ID: 23246611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.